Nevertheless, while the time from infection was comparable between SIV and SI, the vast majority of SIV (92%) displayed a superior NA in saliva as well as plasma samples collected 3 months after vaccination, thus highlighting the efficacy of the vaccine booster regimen also in subjects recovered from COVID-19. The gene discussed is XK; the disease is COVID-19.